Abstract
Importance Poor oral health, including periodontal disease, is associated with oral microbiome changes and increased mortality risk. However, no large studies have evaluated whether the oral microbiome is directly associated with mortality.
Objective To evaluate whether measures of the oral microbiome is prospectively associated with all-cause mortality.
Design A cross-sectional survey with samples collected from 2009-2012 and mortality linkage to the restricted-use National Death Index (NDI) through 2019.
Setting The National Health and Nutrition Examination Survey (NHANES) 2009-2012, a multistage probability sample of the US population.
Participants NHANES participants 20- to 69-years-old who were eligible for linkage to the NDI and provided oral rinse specimens (N=7,721, representing approximately 194 million individuals).
Exposure Oral microbiome ascertained by sequencing the V4 region of the 16S rRNA gene of extracted DNA from oral rinse specimens. Alpha diversity, beta diversity, and genus-level data were generated using DADA2 and QIIME.
Main outcome and measure All-cause mortality.
Results After an average of 8.8 years, a total of 426 participants died. Using Cox proportional hazards regression and after controlling for multiple comparisons where appropriate, continuous alpha diversity was inversely associated with all-cause mortality, but only the association for the Shannon-Weiner index was significant with full adjustment for major risk factors (hazard ratio [HR] per standard deviation [SD]=0.85; 95% confidence interval [CI]=0.74-0.98). The principal coordinate analysis (PCoA) vector 2 from the Bray-Curtis dissimilarity matrix (HR per SD=0.83; 95% CI=0.73-0.93) and PCoA1 from weighted UniFrac (HR per SD=0.86; 95% CI=0.75-0.98) were significantly associated with all-cause mortality after full adjustment. Few associations were observed at the genus-level after Bonferroni correction, but an increase in 1 SD of the relative abundance of Granulicatella and Lactobacillus were associated with a 17% (95% CI=1.11-1.24) and 11% (95% CI=1.06-1.16) increase in mortality risk, respectively. Compared to participants with no detectable Bacteroides, participants in the highest tertile of Bacteroides had decreased mortality risk (HR=0.54; 95% CI=0.40-0.74).
Conclusions and relevance Some measures of the oral microbiome were associated with all-cause mortality in this representative population cohort. These results suggest that oral bacterial communities may be important contributors to health and disease.
Key points Question: Does the human oral microbiome impact an individual’s risk of mortality?
Findings: In this prospective study including 7,721 individuals of which 426 died over follow-up, specific measures of the oral microbiome were associated with all-cause mortality.
Meaning: The microbes living in the oral cavity may play an important role in human health.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.n.cdc.gov/Nchs/Nhanes/omp/
Funding Statement
This study was supported in part by a grant from the National Institute for Dental and Craniofacial Research (R01DE023175), a grant from the US Food and Drug Administration's Center for Tobacco Products, a grant from the National Cancer Institute Informatics Technology for Cancer Research (1U24CA248454-01), the Intramural Research Program of the National Cancer Institute, and Federal funds from the National Cancer Institute, National Institutes of Health, under NCI Contract number 75N910D00024.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Health and Nutrition Examination Survey (NHANES) protocol was approved by the National Center for Health Statistics (NCHS) Ethics Review Board (ERB) and all participants provided written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Unlinked public-use National Health and Nutrition Examination Survey (NHANES) data files are available on the NHANES website (https://www.cdc.gov/nchs/nhanes). The linked mortality (National Death Index) files are available in a public-use version, available online (https://www.cdc.gov/nchs/data-linkage/mortality.htm), and a restricted-use file available for analysis at the National Center for Health Statistics Research Data Center (https://www.cdc.gov/rdc/index.htm). The restricted-use mortality file was used for this analysis.
